Live Breaking News & Updates on Choosing Between Cart Cell Therapy And Bispecific Antibodies

Stay updated with breaking news from Choosing between cart cell therapy and bispecific antibodies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Berdeja on Patient Factors That Drive Treatment Decisions in Multiple Myeloma

Jesus Berdeja, MD, discusses factors to consider when choosing between CAR T-cell therapy and bispecific antibodies in patients with multiple myeloma. ....

United States , Jesus Berdeja , Myeloma Research , Multiple Myeloma Research , Tennessee Oncology , Choosing Between Cart Cell Therapy And Bispecific Antibodies , Patients With Multiple Myeloma ,